Delivery Order SPE2DB20D1047-SPE2DB25FF37Y
Award Date
1/22/25
Potential Completion Date
2/12/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,247.92 firm-fixed-price delivery order contract covers the supply of IBRANCE 75 MG TABLET 7S, a pharmaceutical product, with a period of performance through March 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a $8,065.75 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product, with a completion date of January 13, 2025. The contract is a firm fixed price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,065.75, is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of December 27, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,065.75, is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product, with a period of performance through January 14, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $8,067.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of IBRANCE 75 MG TABLET 7S. The contract is a Firm Fixed Price Delivery Order with a performance period through March 2025. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $7,796.30 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of IBRANCE 100 MG TABLET 7S prescription medication. The award has no set-aside designation and the ultimate contract completion date is September 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999...
This federal contract award, with ID SPE2DB20D1047|SPE2DB25FF47G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $16,244.96. It covers the supply of IBRANCE 100 MG TABLET 7S, a pharmaceutical product, to support federal healthcare programs. The contract is part of a larger Indefinite Delivery...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of IBRANCE 100 MG TABLET 7S, a pharmaceutical product. The contract has a ceiling value of $7,796.30 and runs through July 12, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,797.84 firm fixed-price delivery order is for the supply of 4565333853 - IBRANCE 75 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of August 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...